Are Food Emulsifiers Associated With Increased Cancer Risk?February 23, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Gene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALLAML
Mantle Cell Lymphoma: Drug Combo Improves PFSDecember 12, 2023Mantle Cell LymphomaAggressive LymphomasNon-Hodgkin Lymphoma
FDA approves pirtobrutinib for previously treated CLL/SLLDecember 4, 2023CLLMantle Cell LymphomaMixed TopicsNon-Hodgkin LymphomaIndolent LymphomaB Cell Lymphoma
FDA OKs new agent to block chemotherapy-induced neutropeniaNovember 29, 2023Mixed TopicsAggressive LymphomasB Cell LymphomaDLBCLHodgkin LymphomaIndolent LymphomaMantle Cell Lymphoma
FDA panel voices concerns over 2 lymphoma accelerated approvalsNovember 17, 2023T Cell LymphomasMixed TopicsALLAggressive LymphomasB Cell LymphomaCLLAML
Lymphoma specialist to lead MD Anderson’s cancer medicine divisionAugust 22, 2023B Cell LymphomaMixed TopicsMantle Cell LymphomaDiversity in Medicine
ESMO helps hematologists assess new cancer drugsJune 28, 2023Mixed TopicsCellular TherapyCMLCLLAggressive LymphomasALLAML
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Diversity in MedicinePatient & Survivor CareDLBCLALLAggressive LymphomasAMLB Cell Lymphoma
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLCLLCML
Huge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCellular Therapy
DEI training gives oncology fellows more confidenceJune 22, 2023Diversity in MedicineDLBCLALLAggressive LymphomasAMLB Cell LymphomaCLL
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLAnemiaB Cell Lymphoma
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CareMixed TopicsAggressive LymphomasALLAMLB Cell LymphomaCLL
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareDiversity in MedicineMixed TopicsDLBCLALLAMLAnemia
